CervoMed Inc. Accounts Receivable, before Allowance for Credit Loss
CervoMed Inc. (CRVO) had Accounts Receivable, before Allowance for Credit Loss of $684.74 thousand as of 2013-12-31, per its 10-K/A filed 2014-04-23.
Discontinued › Balance Sheet › Assets
us-gaap:AccountsReceivableGross · last filed 2014-04-23
- 2013-12-31: Accounts Receivable, before Allowance for Credit Loss $684.74K.
- 2013-09-30: Accounts Receivable, before Allowance for Credit Loss $735.74K.
- 2013-06-30: Accounts Receivable, before Allowance for Credit Loss $741.41K.
- 2013-03-31: Accounts Receivable, before Allowance for Credit Loss $754.67K.
| Period end | Accounts Receivable, before Allowance for Credit Loss |
|---|---|
| 2013-12-31 | $684.74K 10-K/A · filed 2014-04-23 |
| 2013-09-30 | $735.74K 10-Q · filed 2013-11-19 |
| 2013-06-30 | $741.41K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $754.67K 10-Q/A · filed 2013-05-20 |
| 2012-12-31 | $754.67K 10-K/A · filed 2014-04-23 |
| 2012-09-30 | $682.72K 10-Q · filed 2012-11-19 |
| 2011-12-31 | $678.10K 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |